Exploring the Active Compounds of Traditional Mongolian Medicine Baolier Capsule (BLEC) in Patients with Coronary Artery Disease (CAD) Based on Network Pharmacology Analysis, Molecular Docking and Experimental Validation

References

• Moraga P. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210. doi:10.1016/S0140-6736(17)32152-9
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681. doi:10.1016/S0140-6736(10)61350-5
   PubMed Web of Science ®Google Scholar
• Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387–2397. doi:10.1056/NEJMoa1410489
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–1722. doi:10.1056/NEJMoa1615664
   PubMed Web of Science ®Google Scholar
• Bowman L, Hopewell JC, Chen F, et al. Effects of anacetrapib in patients with atherosclerotic vascular disease. N Engl J Med. 2017;377:1217–1227. doi:10.1056/NEJMoa1706444
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar
• Bayat A, Azizi-Soleiman F, Heidari-Beni M, et al. Effect of Cucurbita ficifolia and probiotic yogurt consumption on blood glucose, lipid profile, and inflammatory marker in type 2 diabetes. Int J Prev Med. 2016;7:30. doi:10.4103/2008-7802.175455
   PubMedGoogle Scholar
• Feng X, Zhang R, Li J, et al. Syringa pinnatifolia Hemsl. fraction protects against myocardial ischemic injury by targeting the p53-mediated apoptosis pathway. Phytomedicine. 2019;52:136–146. doi:10.1016/j.phymed.2018.09.188
   PubMed Web of Science ®Google Scholar
• Gaowa S, Bao N, Da M, et al. Traditional Mongolian medicine Eerdun Wurile improves stroke recovery through regulation of gene expression in rat brain. J Ethnopharmacol. 2018;222:249–260. doi:10.1016/j.jep.2018.05.011
   PubMed Web of Science ®Google Scholar
• Qiburi Q, Ganbold T, Bao Q, et al. Bioactive components of ethnomedicine Eerdun Wurile regulate the transcription of pro-inflammatory cytokines in microglia. J Ethnopharmacol. 2020;246:112241. doi:10.1016/j.jep.2019.112241
   PubMed Web of Science ®Google Scholar
• Ge H, Wang A, Su Y, et al. Ameliorative effects of Qingganjiuwei powder, a traditional Mongolian medicine, against CCl4-induced liver fibrosis in rats. J Ethnopharmacol. 2021;264:113226. doi:10.1016/j.jep.2020.113226
   PubMed Web of Science ®Google Scholar
• Gang H, Feng H, Huai S. Study on the hypolipidemic effect of Mongolian medicine Baolier capsules. Chin J Tradit Med. 2017;23:10. Chinese. doi:10.16041/j.cnki.cn15-1175.2017.10.042
   Google Scholar
• Ahmed SS, Ramakrishnan V. Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS One. 2012;7:e40654. doi:10.1371/journal.pone.0040654
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–D612. doi:10.1093/nar/gkaa1074
   PubMed Web of Science ®Google Scholar
• Caballero-Solares A, Hall JR. Reverse Transcription-Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR) for gene expression analyses. Methods Mol Biol. 2022;2508:319–340.
   PubMedGoogle Scholar
• Na S, Wu R, Chen X. Past present and future of treating angina pectoris with Mongolian medicine dialectics thinking. Chin J Cardiol Med. 2019;24:112–114. Chinese. doi:10.3969/j.issn.1007-5410.2019.02.005
   Google Scholar
• Shi Y, Dun S, Chen D, et al. Bioactive compounds from Polygonatum genus as anti-diabetic agents with future perspectives. Food Chem. 2022;408:135183. doi:10.1016/j.foodchem.2022.135183
   PubMed Web of Science ®Google Scholar
• Carbone K, Gervasi F. An updated review of the genus Humulus: a valuable source of bioactive compounds for health and disease prevention. Plants. 2022;11(24):3434. doi:10.3390/plants11243434
   Google Scholar
• Stefanucci A, Scioli G, MarinaccioA L, et al. Comparative study on phytochemical fingerprint of two diverse Phaseolus vulgaris var. Tondino del Tavo and Cannellino bio extracts. Antioxidants. 2022;11(8):1474. doi:10.3390/antiox11081474
   Web of Science ®Google Scholar
• Shen Y, Ward NC, Hodgson JM, et al. Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1. Free Radic Biol Med. 2013;65:908–915. doi:10.1016/j.freeradbiomed.2013.08.185
   PubMed Web of Science ®Google Scholar
• Jiang YH, Jiang LY, Wang YC, et al. Quercetin attenuates atherosclerosis via modulating oxidized LDL-induced endothelial cellular senescence. Front Pharmacol. 2020;11:512. doi:10.3389/fphar.2020.00512
   PubMed Web of Science ®Google Scholar
• Luo M, Tian R, Lu N. Quercetin inhibited endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice: critical roles for NADPH oxidase and heme oxygenase-1. J Agric Food Chem. 2020;68:10875–10883. doi:10.1021/acs.jafc.0c03907
   PubMed Web of Science ®Google Scholar
• Lin W, Wang W, Wang D. Quercetin protects against atherosclerosis by inhibiting dendritic cell activation. Mol Nutr Food Res. 2017;61. doi:10.1002/mnfr.201700031
   Web of Science ®Google Scholar
• Cao H, Jia Q, Yan L, et al. Quercetin suppresses the progression of atherosclerosis by regulating MST1-Mediated Autophagy in ox-LDL-Induced RAW264.7 macrophage foam cells. Int J Mol Sci. 2019;20(23):6093. doi:10.3390/ijms20236093
   PubMed Web of Science ®Google Scholar
• Jia Q, Cao H, Shen D, et al. Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARgamma, LXRalpha and ABCA1. Int J Mol Med. 2019;44:893–902. doi:10.3892/ijmm.2019.4263
   PubMed Web of Science ®Google Scholar
• Garelnabi M, Mahini H, Wilson T. Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation. J Int Soc Sports Nutr. 2014;11:22. doi:10.1186/1550-2783-11-22
   PubMed Web of Science ®Google Scholar
• Li SS, Cao H, Shen DZ, et al. Effect of quercetin on atherosclerosis based on expressions of ABCA1, LXR-alpha and PCSK9 in ApoE(-/-) Mice. Chin J Integr Med. 2020;26:114–121. doi:10.1007/s11655-019-2942-9
   PubMed Web of Science ®Google Scholar
• Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009;9:31–59. doi:10.2174/138955709787001712
   PubMed Web of Science ®Google Scholar
• Li J, Dong JZ, Ren YL, et al. Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages. Exp Ther Med. 2018;16:2593–2599. doi:10.3892/etm.2018.6499
   PubMed Web of Science ®Google Scholar
• Ding X, Zheng L, Yang B, et al. Luteolin attenuates atherosclerosis via modulating signal transducer and activator of transcription 3-mediated inflammatory response. Drug Des Devel Ther. 2019;13:3899–3911. doi:10.2147/DDDT.S207185
   PubMed Web of Science ®Google Scholar
• Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, et al. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11:298–344. doi:10.2174/138955711795305335
   PubMed Web of Science ®Google Scholar
• Kong L, Luo C, Li X, et al. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. Lipids Health Dis. 2013;12:115. doi:10.1186/1476-511X-12-115
   PubMed Web of Science ®Google Scholar
• Jourdan PS, McIntosh CA, Mansell RL. Naringin levels in citrus tissues: II. Quantitative distribution of naringin in citrus paradisi MacFad. Plant Physiol. 1985;77(4):903–908. doi:10.1104/pp.77.4.903
   PubMed Web of Science ®Google Scholar
• Mulvihill EE, Assini JM, Sutherland BG, et al. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 2010;30:742–748. doi:10.1161/ATVBAHA.109.201095
   PubMed Web of Science ®Google Scholar
• Assini JM, Mulvihill EE, Sutherland BG, et al. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr(-)/(-) mice. J Lipid Res. 2013;54:711–724. doi:10.1194/jlr.M032631
   PubMed Web of Science ®Google Scholar
• Burke AC, Sutherland BG, Telford DE, et al. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr(-/-) mice. Atherosclerosis. 2019;286:60–70. doi:10.1016/j.atherosclerosis.2019.05.009
   PubMed Web of Science ®Google Scholar
• Orhan IE, Nabavi SF, Daglia M, et al. Naringenin and atherosclerosis: a review of literature. Curr Pharm Biotechnol. 2015;16:245–251. doi:10.2174/1389201015666141202110216
   PubMed Web of Science ®Google Scholar
• Tian XH, Wu JH. Tanshinone derivatives: a patent review (January 2006–September 2012). Expert Opin Ther Pat. 2013;23:19–29. doi:10.1517/13543776.2013.736494
   PubMed Web of Science ®Google Scholar
• Chen W, Li X, Guo S, et al. Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis. Int Immunopharmacol. 2019;70:486–497. doi:10.1016/j.intimp.2019.02.054
   PubMed Web of Science ®Google Scholar
• Chen W, Guo S, Li X, et al. The regulated profile of noncoding RNAs associated with inflammation by tanshinone IIA on atherosclerosis. J Leukoc Biol. 2020;108:243–252. doi:10.1002/JLB.3MA0320-327RRR
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu Y, Ren G, et al. Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 2017;815:427–436. doi:10.1016/j.ejphar.2017.09.047
   PubMed Web of Science ®Google Scholar
• Chen W, Tang F, Xie B, et al. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol. 2012;674:359–364. doi:10.1016/j.ejphar.2011.10.040
   PubMed Web of Science ®Google Scholar
• Tan YL, Ou HX, Zhang M, et al. Tanshinone IIA promotes macrophage cholesterol Efflux and attenuates atherosclerosis of apoE-/- mice by omentin-1/ABCA1 pathway. Curr Pharm Biotechnol. 2019;20:422–432. doi:10.2174/1389201020666190404125213
   PubMed Web of Science ®Google Scholar
• Tang FT, Cao Y, Wang TQ, et al. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Eur J Pharmacol. 2011;650:275–284. doi:10.1016/j.ejphar.2010.07.038
   PubMed Web of Science ®Google Scholar
• Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150–1155. doi:10.1056/NEJM199605023341802
   PubMed Web of Science ®Google Scholar
• Shaish A, Daugherty A, O’Sullivan F, et al. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest. 1995;96:2075–2082. doi:10.1172/JCI118256
   PubMed Web of Science ®Google Scholar
• Luo Y, Sun G, Dong X, et al. Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction. PLoS One. 2015;10:e120259. doi:10.1371/journal.pone.0120259
   PubMed Web of Science ®Google Scholar
• Fernandez-Hernando C, Ackah E, Yu J, et al. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 2007;6:446–457. doi:10.1016/j.cmet.2007.10.007
   PubMed Web of Science ®Google Scholar
• Patino WD, Mian OY, Kang JG, et al. Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci U S A. 2005;102:3423–3428. doi:10.1073/pnas.0408032102
   PubMed Web of Science ®Google Scholar
• Chen Q, Lv J, Yang W, et al. Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics. 2019;9:6424–6442. doi:10.7150/thno.35528
   PubMed Web of Science ®Google Scholar
• Guevara NV, Kim HS, Antonova EI, et al. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999;5:335–339. doi:10.1038/6585
   PubMed Web of Science ®Google Scholar
• Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317–1542. doi:10.1152/physrev.00004.2012
   PubMed Web of Science ®Google Scholar
• Zeboudj L, Giraud A, Guyonnet L, et al. Selective EGFR (epidermal growth factor receptor) deletion in myeloid cells limits atherosclerosis-brief report. Arterioscler Thromb Vasc Biol. 2018;38:114–119. doi:10.1161/ATVBAHA.117.309927
   PubMed Web of Science ®Google Scholar
• Heinonen SE, Kivela AM, Huusko J, et al. The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovasc Res. 2013;99:716–723. doi:10.1093/cvr/cvt148
   PubMed Web of Science ®Google Scholar